Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,541 | 159,570 | 191,173 | 59,739 | 105,138 |
| Marketable Securities | 67,039 | 43,250 | 66,505 | 106,727 | 103,353 |
| Receivables | 35,499 | 43,086 | 42,615 | 38,525 | 41,850 |
| Inventories | 48,382 | 41,502 | 42,800 | 42,629 | 41,905 |
| TOTAL | $254,423 | $315,052 | $366,826 | $272,288 | $314,196 |
| Non-Current Assets | |||||
| PPE Net | 23,734 | 22,788 | 22,175 | 22,704 | 22,737 |
| Other Non-Current Assets | 27,549 | 14,548 | 15,249 | 15,940 | 16,623 |
| TOTAL | $51,283 | $37,336 | $37,424 | $38,644 | $39,360 |
| Total Assets | $305,706 | $352,388 | $404,250 | $310,932 | $353,556 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,803 | 5,885 | 11,242 | 1,689 | 525 |
| Accrued Expenses | 38,979 | 33,157 | 37,588 | 63,848 | 63,559 |
| TOTAL | $71,058 | $72,296 | $82,143 | $100,917 | $102,503 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 157,078 | 161,249 | 161,995 | 13,790 | 14,561 |
| TOTAL | $157,078 | $161,249 | $161,995 | $13,790 | $14,561 |
| Total Liabilities | $228,136 | $233,545 | $244,138 | $114,707 | $117,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,141 | 101,935 | 101,910 | 101,829 | 91,397 |
| Common Shares | 1,020 | 1,019 | 1,019 | 914 | 913 |
| Retained earnings | -1,613,431 | -1,558,785 | -1,506,377 | -1,445,362 | -1,392,748 |
| Other shareholders' equity | -6 | -4 | 41 | 121 | 257 |
| TOTAL | $77,570 | $118,843 | $160,112 | $196,225 | $236,492 |
| Total Liabilities And Equity | $305,706 | $352,388 | $404,250 | $310,932 | $353,556 |